ALEXANDREA KINNEY: Open Payments
NPI 1114688082 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,906 in 155 payments from 21 companies in 2025. Trend: 2023 $1,051 · 2024 $2,320 · 2025 $2,906
Food & beverage: $2,906
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $801 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $419 |
| GENZYME CORPORATION | 18 | $323 |
| Janssen Biotech, Inc. | 11 | $206 |
| Madrigal Pharmaceuticals | 11 | $170 |
| Ipsen Biopharmaceuticals, Inc | 8 | $141 |
| Celltrion USA Inc. | 6 | $121 |
| Aimmune Therapeutics, Inc. | 5 | $109 |
| PFIZER INC. | 4 | $102 |
| Lilly USA, LLC | 3 | $78 |
Products named: DUPIXENT, RINVOQ, SKYRIZI, ENTYVIO, TREMFYA, REZDIFFRA, LINZESS, IQIRVO.
Industry payments across OH — which companies pay providers there.
